logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

WISDOMCOME GP(08079) subsidiary issued a loan of HKD 4.8 million.

date
17:38 07/09/2023
avatar
GMT Eight
On August 2, 2023, WISDOMCOME GP (08079) issued an announcement stating that a loan agreement was entered into between the creditor (Easy Repay Financial Limited, a subsidiary of the company) and the borrower, Mr. Cai Fengyuan. Accordingly, the creditor agreed to grant a secured loan amount of HKD 4.8 million to the borrower.
Related Articles
China Stock
Ningbo Construction (601789.SH) subsidiary consortium won the bid for a construction project worth 747 million yuan.
China Stock
Guangdong Zhengye Technology (300410.SZ) signed a 120 million yuan X-ray equipment contract.
China Stock
Ningbo Menovo Pharmaceutical's subsidiary, the raw material of Atorvastatin calcium, passed the CDE technology evaluation.
Ningbo Construction (601789.SH) subsidiary consortium won the bid for a construction project worth 747 million yuan.
China Stock
Guangdong Zhengye Technology (300410.SZ) signed a 120 million yuan X-ray equipment contract.
China Stock
Ningbo Menovo Pharmaceutical's subsidiary, the raw material of Atorvastatin calcium, passed the CDE technology evaluation.
China Stock
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
icon
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
icon
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
icon
16/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.